Artificial intelligence has aided in the advancement of healthcare research. The availability
of open-source healthcare statistics has prompted researchers to create applications that aid …

Abstract The CellSearch® system (CS) enables standardized enrichment and enumeration
of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive “liquid …

Abstract Background Circulating tumor cells (CTCs) have been shown to predict reduced
survival outcomes in metastatic breast cancer. Methods CTCs were analyzed in 2026 …

Ultrasensitive methods have been recently developed to detect circulating tumour cells
(CTCs) in the peripheral blood and disseminated tumour cells (DTCs) in the bone marrow …

Background The identification of circulating tumour cells correlate with poor prognosis in
metastatic breast cancer, but there are few data describing the importance of circulating …

Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new
cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon …

Abstract Oestrogen receptor (ER)-positive—or luminal—tumours represent around two-
thirds of all breast cancers. Luminal breast cancer is a highly heterogeneous disease …

Purpose: The prognostic value of circulating tumor cells (CTC) detected in breast cancer
patients is currently under debate. Different time points of blood collections and various CTC …

The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid
malignant tumors becomes increasingly important as it may serve as a 'liquid biopsy'with the …

Purpose: This study was aimed at detecting and characterizing circulating tumor cells (CTC)
before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast …